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Abstract
Background: The adaptive immune response requires waves of T-cell clonal expansion on contact
with pathogen and elimination after clearance of the source of antigen. However, lifelong persistent
infections with common viruses cause chronic antigenic stimulation which takes its toll on adaptive
immunity in late life. Chronic antigenic stress results in deregulation of the T-cell response and
accumulation of anergic cells. Longitudinal studies of the elderly show that this impacts on survival.
Identifying the nature of the defects in chronically-stimulated T-cells and protein bio-markers of
these dysfunctional cells would help to understand age-associated compromised T-cell function
(immunosenescence) and facilitate the development of targeted intervention strategies.
The purpose of this work was to use surface-enhanced laser desorption/ionization time-of-flight
mass spectrometry (SELDI-TOF-MS) to analyse proteins associated with T-cell senescence in order
to identify potential bio-markers. Clonal populations of T-cells isolated from elderly octogenarian
and centenarian donors were grown in vitro until senescence, and early passage and late passage
(pre-senescent) cells were analysed using SELDI-TOF-MS ProteinChip arrays.
Results: Discriminant analysis identified several protein or peptide peaks in the region of 14.5–
16.5 kDa that were associated with T-cell clone senescence. Human profilin-1, a ubiquitous protein
associated with actin remodelling and cellular motility was unambiguously identified. Altered
expression of profilin-1 in senescent T-cell clones was confirmed by Western blot analysis.
Conclusion: Due to the proposed roles of profilin-1 in cellular survival, cytoskeleton remodelling,
motility, and proliferation, it is hypothesised that differential expression of profilin-1 in ageing may
contribute directly to immunosenescence.
Background
Immunosenescence – or dysfunction of the immune
response that occurs during ageing-- contributes signifi-
cantly to increased morbidity and mortality in the elderly
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population [1-3]. Dysfunctional immunity in ageing is
particularly prevalent in the T-cell compartment; T-cells
derived from elderly individuals show poor proliferative
responses, clonal expansion and accumulation of mem-
ory and effector T-cells, and the exhaustion of naïve T-
cells. Immunosenescent T-cells also exhibit dysregulated
signalling pathways in addition to altered adhesion/acti-
vation molecule expression and production of cytokines,
ultimately resulting in phenotypic and functional altera-
tions to T-cell mediated immunity [2,4-7].
In humans, cytomegalovirus (CMV), which is prevalent in
the elderly population, contributes markedly to the per-
sistent clonal expansion of CD8 T-cells observed in ageing
[8-10]. In fact, an immune risk phenotype (IRP) has been
described encompassing bio-markers associated with the
age-related decline in immune function predictive of mor-
tality in longitudinal studies [11]. One of the major char-
acteristic features of human immunosenscence in vivo is
the predominance of clonal expansions of a limited reper-
toire of CD8+/CD28- cells [9,12,13]. The majority of
CD28 negative T-cells can produce pro-inflammatory
cytokines [14] but in the very elderly these cells are further
compromised in the production of all cytokines on anti-
gen-specific challenge [15]. Individuals with the IRP also
exhibit a pro-inflammatory phenotype, providing further
evidence of age related alterations in both innate and
adaptive immune systems [16]. These dysregulated,
immunosenescent T-cells fill up the 'immunological
space' resulting in a general immuno-suppression
through lack of provision of secondary activating signals
– adhesion/activation and soluble mediators.
While attempts have been made to characterize the phe-
notypic changes that occur during T-cell ageing and
immune dysregulation, the mechanistic drivers underly-
ing T-cell immunosenescence are poorly understood. At
the cellular level, age-related loss of immune function is
associated with the accumulation of cells with (1)
decreased membrane fluidity and calcium influx [1] and
(2) signal transduction defects, particularly in the cellular
stress [7] and redox regulatory pathways (reviewed in
[17]). Importantly, regulation of the redox-sensitive tran-
scription factor NFκB is altered in T-cell senescence [18]
and may impact on several different down-stream signal-
ling targets. These data suggest that global regulatory and
signalling networks may be altered in dysfunctional, age-
ing T-cells. Understanding the mechanistic drivers that
lead to the accumulation of dysfunctional cells may allow
the development of an intervention in the elderly to
reconstitute appropriate immune responses. To this end,
in vitro T-cell models of clonal expansion provide useful
tools, enabling the production of adequate sample mate-
rial to investigate the complex mechanistic drivers of T-
cell ageing using 'omic' technologies. Using this in vitro
system to guide the discovery of protein bio-markers of
ageing and immunosenescence in vivo could aid in under-
standing immune dysfunction in the elderly and would
allow development of novel intervention strategies to
restore function [19,20].
The current study utilised surface enhanced laser desorp-
tion/ionisation time-of-flight mass spectrometry (SELDI-
TOF-MS) ProteinChip Array technology (Ciphergen Bio-
systems, Inc., Fremont, CA) for protein profiling of ageing
and senescent T-cells. This method is unique in that it uses
chromatographic surfaces to retain proteins based on
their physicochemical characteristics, followed by TOF-
MS using a ProteinChip Reader (PBSIIc Series 4000;
Ciphergen Biosystems, Inc.). Isolated proteins are sepa-
rated on different array surfaces including cation/anion-
exchangers, hydrophobic and metal-ion affinity surfaces.
Proteins that bind and are retained on the surfaces are
analysed by mass spectrometry (MS). This technique
offers enhanced sensitivity which is ideal for the analysis
of small sample volumes and allows screening of low-
molecular weight proteins. The SELDI-TOF/MS approach
has several advantages for bio-marker analyses. Firstly, it
requires little starting material; secondly, it has a high-
throughput capacity; thirdly it allows semi-quantitative
and statistical analysis; and finally, it can aid in the iden-
tification of purification conditions prior to protein iden-
tification by peptide mass fingerprinting. As such, SELDI
technology has been applied in recent years to investigate
a variety of biological phenomena, due to the increasing
need for high-throughput technology that allows the
detection, purification, and identification of proteins at
high speed and with high sensitivity [21,22].
The main objectives of the current study were to use
SELDI-TOF-MS to profile proteins that were differentially
expressed in chronic antigenic stress-induced T-cell clone
senescence. Protein profiles from T-lymphocytes isolated
from elderly donors grown to pre-senescence in culture
were compared to early passage clones in order to identify
proteins associated with in vitro ageing and senescence.
Using SELDI-TOF-MS analysis, we identified several can-
didate protein or peptide peaks that were preferentially
expressed in late passage T-cell clones. Differential expres-
sion of one protein, human profilin-1, was confirmed by
Western blot analysis comparing early and late passage T-
cell clones. Human profilin-1 is thought to be involved in
cytoskeleton remodelling, adhesion, and proliferation
and migration [23-26], all of which are cellular processes
that may impact on immunosenescence. As such, profilin-
1 may represent a potential bio-marker associated with T-
cell dysfunction and development of senescence.Proteome Science 2007, 5:7 http://www.proteomesci.com/content/5/1/7
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Results
Identification of protein/peptide peaks by SELDI-TOF-MS
In order to determine which proteins are differentially
expressed as cells approach senescence, early and late pas-
sage T-cell clones were analyzed on two different Protein-
Chip array chemistries as described in Materials and
Methods. Samples were grouped based on passage time
and expression difference mapping (EDM) was utilised
(Ciphergen Express™ software). Peaks were assigned in
each sample and those which significantly differed (p <
0.05) between early and late passage T-cell clones were
determined. Figure 1 shows representative spectra
obtained from early and late passage samples.
EDM averages the intensities of each peak for each sample
in the group, in order to determine whether the mean
intensity differs between two groups. As such, in this
approach there is no consideration of how many samples
within a group exhibit the trend, and the result is influ-
enced strongly by outlying samples. In order to visualise
areas of the proteome that differed in the majority of sam-
ples in one group compared to the majority of samples in
the other group, hierarchical clustering was performed
and visualised by heat map, as shown in Figure 2. A heat
map is a graphical representation of the entire array in grid
form, with columns representing samples and rows repre-
senting the m/z of protein/peptide peaks. The intersection
of a peak and sample is coloured according to its expres-
sion value compared to the mean of the entire sample set.
In this analysis red indicates high expression compared to
the mean while green indicates low expression compared
to the mean intensity value. Black colouring indicates no
change from the mean. In addition the intensity of the
colour indicates the extent of over- or under-expression
compared to the mean.
Heat map visualisation of early and late passage T-cells
identified a region between 14.5 kDa and 16.5 kDa which
was highly conserved between individual samples and sig-
nificantly differed between the two groups (Figure 2). In
fact, two peaks within this region, of 14076 Da and 15083
Da, were found to significantly increase in expression
between early and late passage cells, as shown in Figure 3.
These data indicate that this region may contain protein
bio-markers of immunosenescence. In light of these
results, we decided to focus our attempts to identify pro-
teins/peptides located within this size region (14.5–16.5
kDa).
Surface-enhanced laser desorption/ionisation profiles of early and late passage T-cell clones derived from octogenarian donors Figure 1
Surface-enhanced laser desorption/ionisation profiles of early and late passage T-cell clones derived from octo-
genarian donors. CD4+ human T-cell clones from activated peripheral blood lymphocytes of healthy octogenarian donors 
were obtained by limiting dilution in the presence of IL-2. Protein profiling was assessed at timepoints as early as possible in 
antigen-stimulated in vitro culture (at the first population doubling (PD) in which two million cells were available for analysis) 
and approaching replicative senescence (at the penultimate or final PD before clones ceased to replicate). SELDI-TOF-MS anal-
ysis was performed using H50 reversed-phase ProteinChips. Spectra shown are the representative of early passage and late-
passage T-cell clones. Normalised mass (m/z) for each peak (in Daltons (Da)) is demonstrated on the X-axis, while intensity is 
plotted on the Y-axis.Proteome Science 2007, 5:7 http://www.proteomesci.com/content/5/1/7
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Heat map visualisation of early and late passage T-cell clones Figure 2
Heat map visualisation of early and late passage T-cell clones. Data obtained from SELDI analysis of early and late pas-
sage CD4+ human T-cell clones using H50 reversed-phase ProteinChips were visualised by clustering and heat map analysis. A 
region between 14.5 kDa and 16.5 kDa, marked by asterisk, was identified to be highly conserved between individual samples 
and significantly differed between early and late passage T-cell clones.Proteome Science 2007, 5:7 http://www.proteomesci.com/content/5/1/7
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Differentially expressed protein/peptide peaks within the region of 14.5–16.5 kDa Figure 3
Differentially expressed protein/peptide peaks within the region of 14.5–16.5 kDa. Early-passage and late-passage T-
cell clones were clustered into two comparative groups for analysis, for a total of 15 samples in each of the two groups, ana-
lyzed in triplicate. From the list of peak clusters created between 14.5 kDa and 16.5 kDa m/z, p-values were calculated using 
CiphergenExpress Client software (version 3.0.5.013). Peaks were manually scored for quality and peaks with signal:noise 
ratios (S/N) <5.0 in more than 50% of samples were removed from analysis. SELDI analysis identified two protein/peptide 
peaks that were differentially expressed between early and late passage T-cell clones. p < 0.05 was considered statistically sig-
nificant. Molecular weight (Da), p-value, average mass:charge (m/z), median mass:charge (m/z), standard deviation, and CV are 
demonstrated for these two peaks (a). Representative early and late passage spectra (b) and gel-like view (c) are demonstrated 
for the region between 14.5 and 16.5 kDa.Proteome Science 2007, 5:7 http://www.proteomesci.com/content/5/1/7
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Protein identification by Nano-LC IonTrap MS/MS
In order to determine the identities of the differentially
expressed peaks between 14.5–16.5 kDa it was first neces-
sary to confirm the size of the target proteins and to deter-
mine how much inter-experiment variability was
introduced by SELDI analysis. For this purpose, lysates
from several clones were pooled and enriched under the
same reversed-phase conditions that were used in the H50
ProteinChip. Reversed-phase high-performance liquid
chromatography (RP-HPLC) was performed in order to
compare mass obtained from SELDI analysis to more
accurate MALDI-TOF MS. RP-HPLC-purified samples
were run in parallel on SELDI-TOF (on a NP20 normal-
phase ProteinChip) and MALDI-TOF mass spectrometers.
One peak of 14.9 kDa identified as differentially
expressed in T-cell senescence is demonstrated by MALDI-
TOF and SELDI-TOF mass spectrometric analysis (Figures
4A and 4B, respectively). M/z comparison of the 14.9 kDa
within both samples demonstrated concordance within
20Da.
In order to identify the 14.9 kDa protein, SDS-PAGE pre-
fractionation, tryptic digestion, and LC-MALDI-MS/MS of
pooled T-cell clone lysates was performed. MASCOT data-
base searching identified several different proteins from
the SDS-PAGE region <25 kDa, as shown in Table 1. Sev-
eral highly abundant bovine proteins were artefacts of the
culture medium. However, only two human proteins,
human ribosomal protein S16 and human profilin-1,
were unambiguously identified within the target region of
14.5–16.5 kDa. Because of the high MOWSE score of
human profilin-1 and its described role in cellular motil-
ity, survival and signalling pathways, we focussed our
attempts in confirming differential expression of profilin-
1 in T-cell clone senescence by Western blot analysis.
Confirmation of differential expression of profilin-1
In order to confirm differential expression of profilin-1 in
T-cell clone senescence, proteins from early and late pas-
sage clones derived from octogenarian donors were ana-
lysed by Western blotting. A representative example of
profilin-1 expression in T-cell clones derived from three
octogenarian donors is shown in Figure 5. Because cofilin,
a protein with opposing roles to profilin, was also identi-
fied by nano-LC IonTrap MS/MS -although it was outside
the region of interest--its expression was also analysed by
Western blotting. While profilin-1 expression was signifi-
cantly increased in senescent T-cells, no such trend was
observed for cofilin expression.
We next investigated whether profilin expression was
altered in senescent cells from other elderly donors. For
this purpose T-cell clones were isolated from centenarian
donors and profilin-1 expression was analysed by Western
blotting, as shown in Figure 6. A representative image of
profilin-1 expression in one T-cell clone from one octoge-
narian and one centenarian donor is depicted in Figure
6a. Average profilin-1 expression from 3–5 clones each
from 3 octogenarian and 3 centenarian donors was deter-
mined at early and late passage, and is shown in Figure 6b.
In agreement with data obtained from SELDI-TOF-MS
analysis, profilin-1 expression is increased in senescent T-
cells derived from both octogenarian and centenarian
donors.
Discussion
Clonal expansion under conditions of chronic antigenic
stress is thought to contribute to the altered immune sta-
tus in the elderly [27]. The accumulation of large numbers
of dysfunctional, senescent cells is an important parame-
Comparative m/z determination of the 14.9 kDa differentially  expressed protein/peptide peak Figure 4
Comparative m/z determination of the 14.9 kDa dif-
ferentially expressed protein/peptide peak. Lysates 
from several clones were pooled and enriched under the 
same reversed-phase conditions that were used in the H50 
ProteinChip SELDI analysis. Reversed-phase high-perform-
ance liquid chromatography (HPLC) was performed in order 
to compare mass obtained from SELDI analysis to more 
accurate MALDI-TOF MS. HPLC-purified samples were run 
in parallel on SELDI-TOF (on a normal-phase ProteinChip) 
and MALDI-TOF mass spectrometers. One peak of 14.9 kDa 
identified as differentially expressed in T-cell senescence is 
demonstrated by MALDI-TOF (a) and SELDI-TOF (b) mass 
spectrometric analysis.Proteome Science 2007, 5:7 http://www.proteomesci.com/content/5/1/7
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ter associated with the "Immune Risk Phenotype" which
predicts mortality in free-living elderly people [28,29].
Understanding the underlying biochemical alterations
associated with altered T-cell function and the senescent
phenotype is essential for developing rational interven-
tion strategies. Therefore the purpose of the present study
was to use SELDI-TOF-MS to investigate differential pro-
tein expression profiles in chronically stimulated T-cell
clones as they approach senescence.
In this approach, we first detected differentially expressed
proteins by SELDI-TOF-MS, confirmed the mass of these
peaks by RP-HPLC and MALDI-TOF (LC-MALDI), and
finally identified the proteins by nano-LC-ESI-MS/MS
analysis. We focussed our efforts in this initial study to
investigate proteins identified in the region of 14.5–16.5
kDa, because this area appeared to be enriched for bio-
markers of immunosenescence. Advantages of the SELDI
technique compared to traditional proteomic techniques
include (1) ease of analysis of protein or protein conju-
gates in serum and patient samples, (2) functional surface
chemistries allow enrichment of proteins and peptides
and (3) rapid scanning and high sample throughput.
While Nano-LC-ESI-MS/MS provides a higher informa-
tion output than SELDI-TOF-MS, it is designed for a lower
throughput of samples to be analysed. Therefore, by com-
bining these two techniques, we maximise sample
throughput while allowing heightened information out-
put.
The majority of proteins we identified with this approach
were either (1) artefacts of large bovine serum proteins
present in the extract or (2) proteins outside of the range
of interest, as shown in Table 1. Several factors resulted in
the co-migration of bovine serum proteins with proteins
of interest thereby hampering attempts to identify the lat-
ter: (1) cells were cultured in the presence of bovine-
derived serum, and (2) proteins of interest were in low
abundance, as evident by relatively low signal:noise
ratios. However, the 14.9 kDa protein peak present in
both RP-HPLC-purified and ProteinChip-enriched sam-
ples was unambiguously identified as human profilin-1
by LC-ESI-MS/MS, with a high associated MOWSE score
of 224 and sequence coverage of 43%. A MASCOT data-
base MOWSE score of 67 is associated with a p value of
<0.05. Therefore, a MOWSE score of 224 gives a high
degree of confidence in the identification of human profi-
lin-1. Furthermore, the differential expression of profilin-
1 was proven by Western blot analysis.
Human profilin-1 is a widely and highly expressed 14 kDa
cytoplasmic protein. Profilin proteins are thought to play
a central role in the regulation of de novo actin assembly
by preventing spontaneous actin polymerisation through
the binding of actin monomers and addition of mono-
meric actin to the barbed actin-filament ends. All stages of
lymphocyte development and activation are associated
with profound changes in cell morphology that depend
on actin cytoskeletal remodelling. These include lym-
phocyte migration, homing into lymphoid organs, inter-
action with antigen-presenting cells, and adherence to
target cells. During lymphocyte maturation, T-cell and B-
cell precursors are in continuous contact with stromal
cells and these physical contacts are critical for differenti-
ation and selection. Because many signalling molecules
are associated with cytoskeletal scaffolds, the cytoskeletal
Table 1: Protein Identification by Nano-LC IonTrap MS/MS
ACCESSION NUMBER PROTEIN ID MOWSE SCORE NOMINAL MASS
A35714 Fetuin precursor (bovine) 222 38394
ABBOS Serum albumin precursor (bovine) 204 71221
ARF4_HUMAN ADP-ribosylation factor 4 (human) 87 20481
COF1-HUMAN Cofilin-1 (human) 47 18588
CSHUA Peptidylprolyl isomerase A (human) 83 18229
R3UH16 Ribosomal protein S16 (human) 87 16549
HBBOF Haemoglobin beta chain, fetal (bovine) 214 15963
PROF1-HUMAN Profilin-1 (human) 224 14923
HABO Haemoglobin alpha chain (bovine) 136 15044
H2AQ_HUMAN Histone H2A.q (human) 63 13849
H2B_HUMAN Histone HsB (human) 112 13752
HSHUB1 Histone H2B.1 (human) 71 13606
A48219 Calvasculin (human) 35 11721
LPHUA2 Apolipoprotein A-II precursor (human) 67 11168
LPHUC3 Apolipoprotein C-III precursor (human) 48 10846
BCHUY Calcyclin (human) 36 10173
1C3TA Ubiquitin mutant YES (human) 120 8560
1TBEB Tetraubiquitin, chain B (human) 140 8176
Protein accession number, identity, MOWSE score and predicted mass (Da) are shown.Proteome Science 2007, 5:7 http://www.proteomesci.com/content/5/1/7
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structure can directly regulate the molecular dynamics of
signalling and biochemical responses.
The major components of the profilin-1 cytoskeleton
remodelling complex are clathrin, valosine-containing
protein (VCP), HSP 70, tubulin and actin [30]. It is note-
worthy that VCP, which is found in the profilin-1 com-
plex, is a major target for tyrosine phosphorylation
following T-cell stimulation [31]. These data suggest that
profilins may be involved in tyrosine phosphorylation
signal transduction pathways. Furthermore, it was
recently hypothesized that profilin may act as a negative
regulator by buffering effector molecules that would oth-
erwise be recruited and activated through SH3-domain-
containing linkers [30]. In this way, profilin over-expres-
sion may lead to disrupted intra-cellular signalling and
inter-cellular communication.
Efforts to define the molecular basis of cellular adhesion,
underlying signal transduction pathways, and their
importance in cell-cell communication and cell-matrix
interactions have progressed a great deal in the last ten
years. The involvement of adhesion molecules in signal
transduction pathways has been well documented. Profi-
lin is known to be physically associated with phosphati-
dylinositol 4,5-bisphosphate (PIP2) and
phosphatidylinositol 3-kinase (PI-3-kinase) products and
functions as a link between cytoplasmic signalling and
actin assembly [23-25,32]. For example, adhesion of T-
cells can be inhibited by wortmannin (an inhibitor of PI-
3-kinase) and cytochalasin B (a disruptor of the actin
cytoskeleton), suggesting that both G protein-sensitive PI-
3-kinase and cytoskeletal assemblies are critical in the
process. It has been reported that integrin-mediated adhe-
sion of endothelial cells to fibronectin was increased by
profilin over-expression and resulted in increased recruit-
ment of fibronectin receptors to the plasma membrane.
This occurred where focal contacts were being formed and
co-localized with focal adhesion proteins [33]. Further-
more, profilin co-localization with spontaneously polym-
erized F-actin was reduced by PI 3-kinase inhibitors or
expression of dominant-negative H-Ras [34]. Taken
Analysis of profilin-1 expression in T-cell clones obtained  from octogenarian and centenarian donors Figure 6
Analysis of profilin-1 expression in T-cell clones 
obtained from octogenarian and centenarian donors. 
For Western blot analysis, one million cells from T-cell 
clones obtained from octogenarian and centenarian donors 
at early, middle and late passage were pelleted and lysed in 
sample buffer (50 mM Tris, pH 8.0, 120 mM NaCl, 0.5% 
NP40, 10 μg/mL PMSF (phenylmethylsulfonylfluoride), and 1× 
protease inhibitor cocktail. A total of 30 μg protein was sus-
pended in laemmli buffer (50 mM tris, pH 6.8, 1% B-mercap-
toethanol, 2% sodium dodecyl sulphate, 0.1% bromophenol 
blue, and 10% glycerol). Samples were boiled and subject to 
Western blot analysis on NuPAGE™ Bis-Tris gels with MES 
running buffer. Human profilin-1 and β-actin proteins were 
detected and visualised by enhanced chemi-luminescence. 
Protein expression profiles from one representative clone 
from an octogenarian and centenarian donor is shown along 
with population doublings (PD) for each sample analysed (A). 
Average profilin-1 expression in early and late passage octo-
genarian and centenarian samples is depicted graphically fol-
lowing normalisation to β-actin expression in each sample 
(B). Student's t-test was performed and p < 0.05 was consid-
ered statistically significant.
Western blot analysis of profilin-1 expression in T-cell clones  obtained from octogenarian donors Figure 5
Western blot analysis of profilin-1 expression in T-
cell clones obtained from octogenarian donors. For 
Western blot analysis, one million cells were pelleted and 
lysed in sample buffer (50 mM Tris, pH 8.0, 120 mM NaCl, 
0.5% NP40, 10 μg/mL PMSF (phenylmethylsulfonylfluoride), 
and 1× protease inhibitor cocktail. A total of 30 μg protein 
was suspended in laemmli buffer (50 mM tris, pH 6.8, 1% β-
mercaptoethanol, 2% sodium dodecyl sulphate, 0.1% 
bromophenol blue, and 10% glycerol). Samples were boiled 
and subject to Western blot analysis on NuPAGE™ Bis-Tris 
gels with MES running buffer. Human profilin-1, cofilin and β-
actin proteins were detected by antibodies as detailed in 
Materials and Methods and visualised by enhanced chemi-lumi-
nescence.Proteome Science 2007, 5:7 http://www.proteomesci.com/content/5/1/7
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together, these data indicate that profilin-1 may play an
important role in the regulation of integrin-mediated T-
cell adhesion and that this function is dependent on PI-3-
kinase signalling.
Several pieces of evidence suggest that PI-3-kinase signal-
ling is impaired in ageing and senescence. Firstly, homol-
ogy has been described between PI-3-kinase catalytic
subunit and Age1, a gene influencing ageing, in
Caenorhabditis elegans [35]. In vitro experiments using PI-
3-kinase inhibitors have demonstrated that inhibition of
PI-3-kinase signalling leads to growth retardation. Since
PI-3-kinase is a major regulator of the cellular stress and
survival response, it may be important to consider that
altered PI-3-kinase and profilin-1 activity or expression in
cellular senescence and ageing may be a response to stress
and may serve to alter the cellular adhesion properties and
signalling cascades.
Several of the proteins identified through the proteomics
analysis reported here, namely human profilin-1, cofilin,
peptidylprolyl isomerase A, cyclophilin A, and ubiquitin-
related proteins have previously been identified as targets
of glutathionylation in oxidatively-stressed T-cells [36]. In
addition, several cytoskeletal and profilin-interacting pro-
teins including vimentin, myosin, tropomyosin, actin,
and HSP70 were also found to be targets of glutathionyla-
tion, suggesting that the actin remodelling process is
tightly regulated by redox status. Protein glutathionyla-
tion may represent a means of redox regulation of protein
function and may play an important role in the ageing
process. Accumulation of damaged proteins in ageing has
been hypothesized to be a major contributor to cellular
senescence, dysfunction and disease. It remains possible
that profilin-1 over-expression associated with immu-
nosenescence might be due to activation of the cellular
stress response and subsequent accumulation of oxida-
tively modified protein which cannot be cleared by the
proteosome. This hypothesis fits with the observation that
profilin-1 -and profilin-1-interacting proteins- are highly
sensitive to oxidative damage. It also agrees with the doc-
umented increased levels of oxidative DNA damage found
in late-passage T-cell clones [37,38]. However, to date,
alterations of expression and activity of these redox-sensi-
tive proteins, including profilin-1, in ageing remains
unexplored.
In addition to the fact that several of the actin-remodel-
ling proteins identified in the current study are targets of
glutathionylation, many of these same proteins -namely
peptidyl-prolyl isomerase A, cofilin and profilin-- have
been demonstrated to be regulated by transforming
growth factor-β (TGF-β) [39]. Because of its function as a
growth factor in regulating inflammation and tissue
repair, it is hypothesized that TGF-β may play a role in
ageing. In fact, a number of polymorphisms within the
TGF-β1 promoter have been described and are associated
with longevity [40,41]. Furthermore, several groups have
associated altered TGF-β activity with ageing and senes-
cence [42-44], demonstrating a potential role for the pro-
tein in contributing to these phenotypes. In concordance
with these data, we have recently found altered TGF-β sig-
nalling in senescent T-cell clones [45]. Accordingly, we
propose that altered profilin-1 expression in senescence
may occur in a TGF-β-dependent manner, concomitant
with a variety of other signalling defects. However, further
research is needed to investigate this hypothesis.
Conclusion
In conclusion, here we report that profilin-1 expression is
up-regulated in T-cell clones approaching senescence.
This finding has important implications for cytoskeletal
remodelling, cellular adhesion, and signalling pathways
in ageing and senescence. We were unable to detect con-
comitant differential expression of other actin-remodel-
ling proteins, including cofilin, suggesting that the actin
polymerisation/depolymerisation homeostasis may be
disrupted. Due to the described signalling role for profi-
lin, it remains probable that altered expression could
impact on a variety of biological processes including cel-
lular survival, proliferation, motility and other as yet
undescribed functions. Of interest, a recently published
study has linked up-regulation of profilin-1 with retinoic-
acid induced inhibition of proliferation and migration
[26]. Combined with the results presented in this paper,
the data strongly suggest that increased expression of pro-
filin-1 may play a direct role in inducing the senescent
phenotype. Therefore, it remains important to further
investigate the biological consequences of altered profi-
lin-1 expression in order to understand the processes
underlying T-cell dysfunction that contribute to immu-
nosenescence. Taken together, the results presented in this
study highlight the discovery of a potential bio-marker of
T-cell dysfunction that may have a diverse impact on cel-




For mass spectrometry, CD4+ human T-cell clones from
activated peripheral blood lymphocytes of healthy octo-
genarian donors were obtained by limiting dilution in the
presence of IL-2 as previously described [19,20]. Five rep-
resentative clones were selected from each of three differ-
ent octogenarian donors at time-points as early as
possible in antigen-stimulated in vitro culture (at the first
population doubling (PD) in which 2 million cells were
available for analysis) and approaching senescence, at the
penultimate or final PD prior to replicative senescence.
These clones were not markedly different in any way fromProteome Science 2007, 5:7 http://www.proteomesci.com/content/5/1/7
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the majority of such clones that we have obtained from
numerous different donors, and at isolation express mark-
ers of effector memory cells (CD45RO++, CD45RB+,
CD45RAlo, CD28lo, CD95++, CCR7lo, and in addition,
carry typical markers of activated T-cells (CD80, CD86,
PD-L1, MHC class II). For SELDI analysis, two million
cells from each clone at each time point were pelleted and
resuspended in lysis buffer (H50: 8 M urea, 2% CHAPS;
Q10: 50 mM Tris-HCl, 5 mM EDTA PH6.0, 2 mM PMSF,
1% Triton X-100) from T-cell clones cryopreserved at early
and late passages. For Western blot analysis, between
three and five T-cell clones were isolated from three octo-
genarian and centenarian donors as previously described




A robotic automation station was utilised for automatic
handling of chips including all binding and washing
steps. The ProteinChip Array BioProcesessor (Ciphergen
Biosystems, Inc., CA, USA) was equipped with 12 Protein-
Chip arrays (Ciphergen Biosystems, Inc., CA, USA), A-H
format. All ProteinChip arrays were pre-treated according
to manufacturer protocols. Binding buffers were 10% ace-
tonitrile/0.1% trifluoroacetic acid (H50) and 50 mM Tris,
pH 8.0 (Q10). Protein lysates from 400,000 cells (10 μl in
100  μl binding buffer) were applied to reversed-phase
hydrophobic surface (H50) and strong anion exchange
(Q10) surfaces. The arrays were incubated and washed
according to manufacturer protocols. After the wells were
dry, 1 μl saturated sinapinic acid (in 50% acetonitrile/
0.5% trifluoracetic acid) was manually added to each
spot. Spots were allowed to air dry and each spot was ana-
lysed in a ProteinChip Reader (Ciphergen Biosystems,
Inc., CA, USA). Each sample was bound to each array sur-
face in triplicate.
Data acquisition and processing
ProteinChip arrays were analysed on a PCS4000 Protein-
Chip Reader using the ProteinChip Software version 4.0
(Ciphergen Biosystems, Inc., CA, USA). Initial arrays were
read at three laser intensities before optimisation at 5000
nJ. The protocol averaged 10 laser shots per pixel with a
focus mass of 18,000 Da, a matrix attenuation of 2500 Da
and a range of 0–50,000 Da. The raw data were analysed
in CiphergenExpress software version 3.0.5.013. The base-
line was subtracted using a setting of 8 times the expected
peak width, as recommended by the software developers.
Ciphergen protein standard (All-IN 1 Protein Standard II,
Ciphergen Biosystems, Inc., CA, USA) was analysed on an
NP20 (normal phase) ProteinChip (Ciphergen Biosys-
tems, Inc., CA, USA) using the same analysis protocol. The
following peaks were identified in the resulting spectrum
and used to create a three-parameter weighted internal
calibration using the CiphergenExpress software (version
3.0.5.013): hirudin BKHV (7033.61 Da), bovine cyto-
chrome c (12230.92 Da) equine cardiac myoglobin
(16951.51 Da) and bovine RBC carbonic anhydrase
(29023.66 Da). This internal calibration was copied and
applied to the spectra as an external calibration. Data were
normalised by total ion current (TIC) to an external nor-
malisation coefficient of 0.2. The low mass cut-off was
2500 Da m/z. Normalised peaks were used exclusively in
data analysis. Expression difference mapping (EDM) was
utilised with automatic peak detection using the settings
of five times the signal-to-noise (S/N) ratio for the first
pass and two times the S/N ratio for the second pass.
Peaks were detected between 2500 Da and 30,000 Da and
a list of peak clusters created for each experimental sam-
ple.
Statistical analysis
Early-passage and late-passage T-cell clones were grouped
for analysis, for a total of 15 samples in each of the two
groups, in triplicate. From the list of peak clusters created,
p-values were calculated using CiphergenExpress software
(version 3.0.5.013). Peaks were manually scored for qual-
ity and peaks with signal:noise ratios (S/N) <5.0 in more
than 50% of samples were removed from analysis. Wil-
coxon signed-rank tests for the matched pairs were per-
formed and p < 0.05 was considered statistically
significant.
Confirmation of m/z by Reversed-Phase High-Performance 
Liquid Chromatography (RP-HPLC) with subsequent 
MALDI-TOF analysis (LC-MALDI)
To confirm the size of proteins of interest and to mimic
the conditions of H50 Ciphergen ProteinChip, RP-HPLC
fractionation on a Shimadzu Micro HPLC system was per-
formed. 20 μl of each lysate was loaded onto a 150 × 2
mm column filled with 5 μm Reprosil C8 material (Grom,
Hailfingen, Germany). A binary gradient was used, with
system A consisting of 0.1% (v/v) TFA/water and system B
consisting of 20% (v/v) System A/acetonitrile (ACN). At a
flow rate of 350 μl/min, the gradient was run for 20 min
on System A to remove the high salt content and then
from 20–100 min from 0–80% System B. The eluting ana-
lytes were detected at 214 nm and 1 minute fractions were
collected (350 μl). Before analysis by MALDI-TOF mass
spectrometry samples were dried by lyophilisation.
Lyophilised HPLC fractions were dissolved in 50 μl HPLC
grade water. 0.5 μl of each fraction were mixed with 0.5 μl
saturated sinapinic acid matrix (in 50% (v/v) ACN/water
with 0.1% (v/v) TFA) and crystallised on a gold MALDI
target (Bruker Daltonik, Bremen, Germany). MALDI-TOF
analysis was performed on a REFLEX IV™ system (Bruker
Daltonik, Bremen, Germany) in the linear mode with
external calibration with Protein Calibration Standard IProteome Science 2007, 5:7 http://www.proteomesci.com/content/5/1/7
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(Bruker Daltonik, Bremen, Germany). 5 μl aliquots of the
samples were used for confirmation of protein mass.
Protein identification
Target proteins in the range below 25 kDa were isolated
and identified as described recently (Tolson et al. 2006).
Briefly, to reduce the complexity of the protein constitu-
ents within the lysates, SDS-PAGE was performed. 40 μg
lysate was separated on a NuPAGE™ 4–12 % Bis-Tris gra-
dient PAGE gel (Invitrogen, Karlsruhe, Germany) with
MES running buffer according to the instructions of the
manufacturer. Proteins were stained using the SimplyB-
lue™ Safe Coomassie system (Invitrogen, Karlsruhe, Ger-
many). The entire region below approximately 25 kDa
was excised into five consecutive bands, diced with a scal-
pel and subjected to in-gel tryptic digestion. All incuba-
tion steps were performed on a thermo-shaker and all
chemicals were from Sigma (Taufkirchen, Germany) if not
otherwise stated. Briefly, diced gel pieces were washed two
times in 50 μl 50 mM NH4HCO3/30% acetonitrile (ACN
for) 10 min at RT and then shrunk in 30 μl ACN for 5 min
at RT. ACN was removed and the sample was dried in a
SpeedVac for 10 min. Reduction of the proteins was per-
formed with 5 μl 10 mM dithiothretol (DTT) in 50 mM
NH4HCO3/30% ACN at 56°C for 40 min. Alkylation was
performed by replacement of the DTT solution by 5 μl 40
mM iodoacetamide in 50 mM NH4HCO3/30% ACN for
30 min at RT in the dark. The gel pieces were washed two
times in 50 μl 50 mM NH4HCO3/30% ACN for 10 min.
After removal of the buffer, 100 μl ACN was added and
the samples dried for 10 min in a SpeedVac. Digestion was
performed by the addition of 250ng sequencing grade
trypsin (Roche Diagnostics, Mannheim, Germany) in 50
μl 50 mM NH4HCO3 and incubation at 37°C overnight.
After centrifugation (10 min 14,000 rpm) the supernatant
was collected. The gel pieces were extracted 2 times with
50 μl 50% (v/v) ACN with 5% (v/v) formic acid and the
extraction solutions added to the supernatant. After
SpeedVac drying the samples were analysed by nanospray
ionisation.
Tryptic peptides were separated on an Agilent 1100 Series
HPLC system (Agilent, Waldbronn, Germany) by Nano-
RP-HPLC with a 100 mm × 75 μm Grom-SIL 120 ODS-3
CP analytical column (Grom, Hailfingen, Germany). Gra-
dient elution was performed at a flow rate of 200nl/min.
The effluent of the analytical column was directly sprayed
into an Esquire 3000plus™ Iontrap MS (Bruker Daltonik,
Bremen, Germany) using an on-line nanoES source
equipped with an 8 μm PicoTip emitter (New Objective,
Woburn, MA, USA).
MS/MS data were analysed using Mascot (www.matrix-
science.com) for probability-based peptide identification
by database matching. The identification of each protein
was evaluated based on percentage of coverage, MOWSE
score (Molecular Weight Search; NCBI), number of pep-
tide matches, peak intensity, and match of pI and molec-
ular weight association with the SELDI-TOF-MS peaks
identified as differentially expressed. Peptide and thus
protein identities were considered significant when a
MOWSE score greater than 35 was achieved and individ-
ual peptide fragmentation spectra showed consistent y-
and b-ion series, which were assigned manually.
Protein analysis
For western blot analysis, one million cells were pelleted
and lysed in sample buffer (50 mM Tris, pH 8.0, 120 mM
NaCl, 0.5% NP40, 10 μg/mL PMSF (phenylmethylsulfo-
nylfluoride), and 1× protease inhibitor cocktail (Sigma, St
Louis, USA). A total of 30 μg protein, as determined by
Bradford assay (Bio-rad, Hercules, California USA) was
suspended in laemmli buffer (50 mM tris, pH 6.8, 1% B-
mercaptoethanol, 2% sodium dodecyl sulphate, 0.1%
bromophenol blue, and 10% glycerol). Protein samples
were boiled, loaded on 10% NuPAGE™ Bis-Tris gels (Inv-
itrogen, United Kingdom) with MES running buffer
according to the instructions of the manufacturer, and
transferred to nitrocellulose membranes (Schleicher and
Schuell, Dassel, Germany). The profilin-1 (Santa Cruz
Biotechnology, USA) and cofilin (Abcam, Cambridge,
UK) proteins were detected using polyclonal antibodies.
β-actin protein was detected using monoclonal antibody
(Abcam, Cambridge, UK). Proteins were visualised by
enhanced chemi-luminescence (GE Healthcare, Bucking-
hamshire, UK).
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